73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Novel therapy studied for inherited breast cancer

Novel therapy studied for inherited breast cancer

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by a

Novel therapy studied for inherited breast cancer

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by a
Team identifies protein key to cancer cells ability to spread

Team identifies protein key to cancer cells ability to spread

by University of GuelphProfessor Jim Uniacke in his specialized lab. Credit: Rob O'FlanaganUniversity of Guelph scientists have made a discovery that could reduce the spread of cancer by hind

Team identifies protein key to cancer cells ability to spread

by University of GuelphProfessor Jim Uniacke in his specialized lab. Credit: Rob O'FlanaganUniversity of Guelph scientists have made a discovery that could reduce the spread of cancer by hind
Team finds key to common cancer pathway

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show
Team develops test to predict immunotherapy response in kidney cancer

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying
Study confirms protein as potential cause of most common type of pancreatic cancer

Study confirms protein as potential cause of most common type of pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Study confirms protein as potential cause of most common type of pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa
Study confirms effectiveness of newer arthritis meds

Study confirms effectiveness of newer arthritis meds

by Amy NortonNewer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.The study, of 622 adul

Study confirms effectiveness of newer arthritis meds

by Amy NortonNewer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.The study, of 622 adul
Team explores anti-breast cancer properties of soy

Team explores anti-breast cancer properties of soy

by University of ArizonaOrnella I. Selmin, PhD (left), and Donato F. Romagnolo, PhD (right). Credit: University of Arizona Cancer CenterA University of Arizona Cancer Center research team is enga

Team explores anti-breast cancer properties of soy

by University of ArizonaOrnella I. Selmin, PhD (left), and Donato F. Romagnolo, PhD (right). Credit: University of Arizona Cancer CenterA University of Arizona Cancer Center research team is enga
Team targets tumor suppressor to treat 'triple-negative' breast cancer

Team targets tumor suppressor to treat 'triple-negative' breast cancer

by University of Arizona Health SciencesAgnieszka Witkiewicz, MD and Erik Knudsen, PhD, UA Cancer Center. Credit: BioCommunications, Kris HanningA study by scientists at the University of Arizona Canc

Team targets tumor suppressor to treat 'triple-negative' breast cancer

by University of Arizona Health SciencesAgnieszka Witkiewicz, MD and Erik Knudsen, PhD, UA Cancer Center. Credit: BioCommunications, Kris HanningA study by scientists at the University of Arizona Canc
Onions and garlic may be recipe for reducing breast cancer risk: study

Onions and garlic may be recipe for reducing breast cancer risk: study

by David J. Hill,University at BuffaloCredit: CC0 Public DomainOnions and garlic are key ingredients in sofrito, a condiment that's a staple of Puerto Rican cuisine. They may also be a recip

Onions and garlic may be recipe for reducing breast cancer risk: study

by David J. Hill,University at BuffaloCredit: CC0 Public DomainOnions and garlic are key ingredients in sofrito, a condiment that's a staple of Puerto Rican cuisine. They may also be a recip
Significant proportion of cancer drugs lack proof of added benefit, finds study

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved
GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6
Ketamine's promise for severe depression grows, but major questions remain

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year